Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Connector enhancer of kinase suppressor of Ras 2 (CNKSR2, also known as CNK2 or MAGUIN) is a multidomain scaffold protein encoded by the *CNKSR2* gene on the X chromosome[1][2][3][5]. It contains domains such as SAM, PDZ, PH, and CRIC, enabling it to interact with multiple proteins in signaling complexes. CNKSR2 regulates the mitogen-activated protein kinase (MAPK) pathway downstream of Ras and coordinates the assembly of synaptic proteins at postsynaptic sites[1][2][3][5]. It plays a critical role in neuronal development, promoting dendrite and dendritic spine formation, and is implicated in various neurodevelopmental disorders including intellectual disability, epilepsy, and autism spectrum conditions[2][3][5]. Defects or mutations in CNKSR2 result in X-linked intellectual disability with associated neurological symptoms. No direct drugs are listed that target CNKSR2, and it is not primarily considered a therapeutic target but is a significant disease gene in neurodevelopmental genetics[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Connector enhancer of kinase suppressor of Ras 2 (CNKSR2).